Clinical Trials
7
Active:0
Completed:6
Trial Phases
3 Phases
Phase 1:2
Phase 2:4
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (57.1%)Phase 1
2 (28.6%)Phase 3
1 (14.3%)Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Phase 1
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SR-T100 Gel
- First Posted Date
- 2015-09-25
- Last Posted Date
- 2019-07-15
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 12
- Registration Number
- NCT02559934
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis
Phase 2
Completed
- Conditions
- Actinic KeratosisBowen's Disease
- Interventions
- Drug: SR-T100 ® Gel
- First Posted Date
- 2014-03-12
- Last Posted Date
- 2014-03-14
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 27
- Registration Number
- NCT02085395
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Phase 1
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: SR-T100 gel
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 2
- Registration Number
- NCT02029066
- Locations
- 🇨🇳
National Cheng Kung University Hospital, Tainan, Taiwan
Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients
Phase 2
Suspended
- Conditions
- Common Wart
- Interventions
- Drug: Vehicle gelDrug: SR-T100 gel with 1.0% of SMDrug: SR-T100 gel with 2.3% of SM
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2023-09-14
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 102
- Registration Number
- NCT01796795
Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs)
Phase 2
Completed
- Conditions
- Genital WartsVenereal WartsCondylomata AcuminataCondyloma Acuminata
- Interventions
- Drug: SR-T100 gel with 1.0 % SMDrug: Vehicle gelDrug: SR-T100 gel with 2.3% SM
- First Posted Date
- 2013-02-22
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- G&E Herbal Biotechnology Co., LTD
- Target Recruit Count
- 138
- Registration Number
- NCT01796821
- Locations
- 🇨🇳
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
🇨🇳Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan
🇨🇳National Cheng Kung University Hospital, Tainan, Taiwan
- Prev
- 1
- 2
- Next
News
No news found